RiverPark Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
NAMA
RiverPark Advisors's EXAS Position: Q2 2022 in Review
RiverPark Advisors sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 215,109 shares — an estimated $15M sold.
RiverPark Advisors first reported a position in EXAS in Q2 2018 and held it in 16 quarters. The position peaked at $20M in Q4 2021. 500 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.
- RiverPark Advisors reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
- RiverPark Advisors sold 215,109 Exact Sciences shares in Q2 2022, an estimated $15M.
- RiverPark Advisors first reported a position in Exact Sciences in Q2 2018 and held it in 16 quarters.
- RiverPark Advisors's Exact Sciences position peaked at $20M in Q4 2021.
- 500 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.
Based on RiverPark Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.